I think that should read November , 2014. Last year they reported on Nov 14 so I would expect them to report around that date. My guess would be Thursday Nov 13, 2014.
Obviously you have never had any serious illness and taken medications with severe side effects. Hep C is not an emergency treatment situation is it? Many patients other than extremely ill will wait for Harvoni, a single treatment with fewer side effects.
A beat is already in the share price unless they continue to beat estimates by 70% like they managed last quarter. Since the estimate is .93 they would have to come in around 1.58 this quarter. Wow , now that would move the share price a little. More likely the guidance next quarter and next year will be part of the boost. they certainly have a wide line of athletic, informal and comfort type shoes. If they reaffirm the margin and growth story why could we not see the mid $60's again by year end?
Good luck with that is right. What makes a new base of 1.80 any time soon? In this market I would wait for another dip into the 1.50's. We already know 14 7 mil is the top line revenue this quarter just closed. Earnings will probably range from what maybe .01 to -.01. I think it is way too hard to narrow down the profit number 1-2-3 quarters out and assign any type of multiple. We know that the revenue will continue to move up. Unless there is a big surprise - pre announcement of revenue kind of eliminates that , why would investors not wait a quarter or two to invest?
What are you talking about --" last true chance to get off the train" & " last few shorts will be flushed out by today" Have any idea how the market works? If GILD recovers a upward direction today there are bound to be sellers glad to get out and a new round of shorts looking for more volatility.
Everyone expects a big beat since they always guide low. Where is the income coming from next quarter? That is what will move the shares. I don't think a 70% beat means anything without guidance that tells a nice revenue story. Nicco needs to ell us Gluu is now on a platform that keeps all quarters positive. This stock has been more of a lottery ticket than an investment. They need to convince investors this is a real sustainable revenue source and not a hit game of the month club.
You really expected to hear management communication regarding what? The Russell 2K has gotten killed and AMOT is down with the rest of the group. Management should prop up the share price by issuing PR to whom.....? I doubt if anything has changed at AMOT. You posted before, no analyst, no firm guidance,great growth story, small cap gem. You just need to be ready for that micro cap type of volatility. I am thinking of a few more shares at this level. If you have been a holder here long term you will remember when we had a few days of "no shares traded" and that was only about a year ago?
Why do you post dribble on covering shorts? You are not spending any ones money unless they sold out on Friday. Even then it was not their money, just paper profits that were riding the Skechers wave. Maybe a investing 101 course over the weekend will enlighten you on the numerous methods to make money in the market. Long term investing usually beats the crack pot traders that jump in and out bragging about their smarts. go away --- I put you on block == IGNORE
FDA approval today and the stock closes down 2.12 a share with the lower general market. No dollars rolling in for you today daejna. Earnings announcement day may be another story. The share price still seems too low.
What exactly do you think they accomplish by dropping the share price after hours? those prices have almost nothing to do with the open the next morning. Your support line means nothing if you look a pre market pps today. The next move will be after earnings when the guidance is in. Everyone expects Harvoni to be approved and the price to remain high. I don't know if approval will necessarily occur 10/10 though.
h8 ignorant? Tell me its not so. He answers his own messages with two more telling himself how brilliant a trader he is to be short. He will have to cover soon when earnings hit the street and the growth story is still alive. Probably will not be much of a short squeeze since I put him on about 10 shares short stake. Need to put him on ignore so I can miss his arrogant messages to stock holders who are up about 20 bucks per share year to date.
If you could guarantee the earnings numbers will not shrink and revenues will grow next year, the share price would reflect that. If the government gets involved in limiting the price of treatments or insurance companies refuse to ante up the 84 K per patient the picture could change in a heartbeat. That is why the share price is 105 a share. Once Harvoni is approved the treatment should be more widely used for Hep C patients because of the much easier to take side effects.
Glad to see you back on the board Q. Nothing has really changed in the KORS story has it , other than the market sediment? I was at a Galleria Mall this weekend and I always make a point of looking at retailers displays and such. In the KORS store I see sales clerks busy with 2 customers and 2 other customers making a purchase. . They carry a few items from the clothing line, full shoe line, watches and handbags at this store. I asked how the cammo line was going and the sales girl told me that is the only line now on sale at this store. Still classic type designs, interesting leathers and colors. My wife gives it 2 thumbs up and wants a new handbag this holiday season. I hate seeing a few KORS handbags and shoes discounted at the DSW shoe store. 3 store fronts away and the Coach store has one sales clerk and no customers.
Don't give your short price right -- price range was 1.74 to 1.66 on Oct 1st. You are shorting to pick up a few cents. What are we learning here-- that .82 cents per share to 1.63 close on Tuesday looks like I have a double in less than a year (Nov 2013). Carry on with your dribble.
I think it will trade after hours market at 110 but close around the 106 mark the day after approval. Are FDA approvals given out late in the day (after hours) or could there be a mid day announcement?. The next big jump in my opinion will come around the earnings announcement and cc with guidance. Everyone believes that Harvoni will be approved.
What makes it a bad stock? The 3 months between earnings reports are generally trading ranges. The stock is only 4 points off its all time high. You want it up every week percentage wise or its a bad stock? What if Harvoni treatment is approved today? Will we then be a good stock again if it jumps 5 %?
The buyback is insignificant compared to the daily trading volume. If they bought shares every day in the quarter , the allotted $$ amount would be about 2 % of the daily volume. How many additional shares get issued every year to board members and officers?
Lack of management support ? Is that referring to the secondary? Negative outlook is all contrived it seems to me. 2 % on margin is negative? The lemmings all jumped ship-- they will be back in once they see growth number again next quarter.